The German software company has updated 40% of the last year, while Danish Pharmaceuticals Novo Nordisk has gradually lost its own half since last summer.
German Technology Institute Chap It rose with the throne of Europe’s largest public company and exceeded it Stock capital Danish drug manufacturer Novo Nordisk.
Software multinational. 40 feeds for profitHe had already experienced its stock market capital in the last year and had 312,000 million euros.
Meanwhile, the Pharmaceutical measures In Copenhagen They lost more than 2%It put the company’s market value slightly above 2.3 billion Danish crowns (309,000 million euros). The company’s activities have lost almost half Its value from last summer has been announced by a 25% increase by 2024 by 2024.
La Fama de Novo NordicMainly because of your VakoviPromoted the company’s shares until the last summer, about 1,000 Danish crowns worth (134 euros), Twice as much as the current price 516 Danish crowns.
But the latest news About the results The company’s new generation drug for weight loss, from the Cagarisma study, They seemed to be disappointed The effects of existing drugs do not show higher effects. The uncertainty pulled the price of the action, which has already lost about 16% this year.
In the meantime, Corporation German won the confidence of investors by starting a strategy to focus Cloud services based on subscriptionsWith additional functions of AI, it promises great income growth.
JP Morgan He recently said that an “attractive procurement opportunity” has emerged as investment bank inspectors reiterated a “high power” rating. About the actions of the company With the purpose of the price of 300 euros.
